Results 201 to 210 of about 138,146 (291)

Examining the Validity and Reliability of Evaluation in Ayres Sensory Integration Data Collected With Autistic Children: A Rasch Analysis

open access: yesAutism Research, EarlyView.
ABSTRACT Performance‐based assessments of sensory function provide essential insights into sensory integration challenges in autistic children and provide objective, standardized measurement data that can be used to tailor targeted interventions. We sought to evaluate the validity and reliability of data collected using the Evaluation in Ayres Sensory ...
Patricia Grady‐Dominguez   +3 more
wiley   +1 more source

A Large‐Scale Study on the Relation Between Multilingualism and Social Traits in Adults With and Without Autism Diagnoses

open access: yesAutism Research, EarlyView.
ABSTRACT Autism Spectrum Disorder is a neurodevelopmental condition characterized by persistent difficulties in social interaction and communication alongside restricted, repetitive patterns of behavior, interests, or activities. Emerging evidence suggests that bi/multilingualism may enhance social interaction skills, yet prior research has largely ...
Margreet Vogelzang   +2 more
wiley   +1 more source

Proposing the ValvUS approach: integrating bedside tests and ultrasonography for severe valvular heart disease diagnosis. [PDF]

open access: yesEinstein (Sao Paulo)
Accorsi TAD   +6 more
europepmc   +1 more source

Cost‐utility analysis of nusinersen–risdiplam switch in patients with spinal muscular atrophy in Croatia: A discrete event simulation model

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić   +4 more
wiley   +1 more source

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Home - About - Disclaimer - Privacy